Target intelligence / Profile preview

Aquaporin 4 (AQP4) (AQP4)

Target
AQP4
Molecular classification
Water channel, Transmembrane protein, Integral membrane protein, Aquaporin family
01

Overview

Aquaporin 4 (AQP4) is a member of the aquaporin family of integral membrane proteins that facilitate the rapid transport of water across cell membranes in response to osmotic gradients [1.2.1]. While most prominently known as the primary water channel in the central nervous system (CNS), AQP4 is also expressed in the colonic epithelium, specifically in the basolateral membranes of surface epithelial cells and crypts [1.3.1]. In the colon, AQP4 plays a significant role in transepithelial water transport and the regulation of fecal water content, with its absence or downregulation linked to altered bowel habits [1.3.2]. In the context of oncology, AQP4 is frequently overexpressed in colon cancer tissues compared to normal mucosa, where it promotes tumor cell migration, invasion, and metastasis, serving as a potential prognostic biomarker [1.1.1, 1.3.3]. Furthermore, AQP4 is the primary autoantigen in Neuromyelitis Optica Spectrum Disorder (NMOSD), an inflammatory demyelinating disease where autoantibodies (AQP4-IgG) trigger complement-mediated astrocyte damage [1.4.5]. Therapeutic strategies include the use of monoclonal antibodies to prevent AQP4-IgG-mediated injury and experimental small molecules or siRNA to modulate its water transport and oncogenic functions [1.4.2, 1.1.4].

Other names
AQP-4Mercurial-insensitive water channelMIWCWCH4HMIWC2
02

Mechanism of action

Inhibition of the complement cascade (C5), depletion of CD19+ B-cells, or blockade of IL-6 signaling to prevent AQP4-autoantibody-mediated damage; experimental direct inhibition of the water channel pore or competitive blockade of autoantibody binding.

03

Biological functions

Water transportOsmoregulationCell migrationPotassium homeostasisWaste removal
04

Disease associations

Colon cancerNeuromyelitis optica spectrum disorder (NMOSD)Brain edemaDiarrheaConstipation
05

Safety considerations

Increased susceptibility to meningococcal infectionsPotential for cerebral edemaDisruption of systemic water homeostasisInfusion-related reactions
06

Interacting drugs

Aquaporumab

4 more in the full profile.

07

Biomarkers

Anti-aquaporin 4 antibody (AQP4-IgG)Aquaporin 4 protein expression (IHC)

Beyond the preview

Go deeper on Aquaporin 4 (AQP4) (AQP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquaporin 4 (AQP4) (AQP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call